COBALT advised Practica Capital on its investment in Oxipit

2019 - 07 - 18

COBALT advised Practica Capital on its latest investment in AI-driven medical imaging startup Oxipit. The Eur 1.5 million seed round was co-led together with participation from Practica Capital, Koinvesticinis Fondas and business angels. The round marks the largest investment into medical AI technology in the Baltic states. It is also one of the largest seed rounds among Baltic startups.

Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit are the authors of CE certified multi-award winning ChestEye radiology imaging suite.

Practica Capital invests in the Baltic innovation and technology-driven ventures. Koinvesticinis fondas is a venture capital co-investment fund. Together with its partners – business angels – fund invests into early-stage companies.

COBALT represented Practica Capital in negotiations and in drafting and coordinating transaction documents, also advised on all matters related to the transaction. The project team was composed of COBALT Partner Elijus Burgis and Associate Julija Timoščenko.

Leading experts